Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teva Plans Action After Losing Opioids Trial In New York

Israeli Firm Is Preparing ‘Swift’ Appeal And Continues To Pursue A Mistrial

Executive Summary

Following a mammoth six-month trial, a jury in New York has issued a verdict finding that Teva and some of its affiliates are liable for the public nuisance charges made by New York state in its opioid trial in Suffolk County State Supreme Court.

You may also be interested in...



Induced Infringement And Price Fixing Among Legal Headlines In 2021

In 2021, courts across the US and beyond continued to weigh key patent litigation fights, alongside the thorny issue of induced infringement via label carve outs and controversial charges for generic price fixing.

Teva And Endo Overcome Opioid Claims In California

Following a recent settlement in Louisiana, Teva has been told by a court in California it is not liable for the state’s opioid crisis, avoiding for now the potential for significant damages.

Teva And Endo Settle Opioid Claims In Louisiana With Millions In Cash

Teva underlined that it was open to further individual state settlements in its broad and sweeping opioid litigation after reaching a deal with the Louisiana Attorney General's office.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

GB151527

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel